Le Lézard
Classified in: Covid-19 virus
Subject: ATY

EIGR LAWSUIT ALERT: Levi & Korsinsky Notifies Eiger BioPharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline


NEW YORK, Dec. 1, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Eiger BioPharmaceuticals, Inc. ("Eiger" or the "Company") (NASDAQ: EIGR) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Eiger investors who were adversely affected by alleged securities fraud between March 10, 2021 and October 4, 2022. Follow the link below to get more information and be contacted by a member of our team:

https://www.zlk.com/pslra-1/eiger-biopharmaceuticals-class-action-lawsuit-submission-form?prid=34162&wire=4

EIGR investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) defendants overstated Eiger's clinical and regulatory drug development expertise; (ii) defendants failed to properly assess, and/or ignored issues with, the design of the TOGETHER study and its ability to support the Emergency Use Authorization ("EUA") for the Company's product candidate, peginterferon lambda ; (iii) there were issues with the conduct of the TOGETHER study and/or the TOGETHER study was not properly designed for the peginterferon lambda EUA in the current context of the pandemic; (iv) as a result, the U.S. Food and Drug Administration was unlikely to approve the submission of a peginterferon lambda EUA; (v) as a result of all the foregoing, peginterferon lambda's regulatory and commercial prospects for the treatment of COVID-19 were overstated; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you suffered a loss in Eiger during the relevant time frame, you have until January 9, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP


These press releases may also interest you

at 08:15
Stem , a global leader in AI-driven clean energy solutions and services, announced its joint eMobility offering with ChargePoint Holdings, Inc. , a leading electric vehicle (EV) charging network. Stem and ChargePoint are developing a joint offering...

at 08:15
Semtech Corporation , a high-performance semiconductor, Internet of Things (IoT) systems and Cloud connectivity service provider, announced the first Software Development Kit (SDK) to enable advanced software-based KVM applications using the...

at 08:15
SinglePoint, Inc. ("SinglePoint" or "the Company") announced today that its subsidiary, BPA Solutions, a premier provider and consultant for clean air services, fulfilled an initial purchase order of Certified HEPA, AIRBOX air purification units to...

at 08:15
Camden National Corporation , a $5.7 billion bank holding company headquartered in Camden, Maine, closed the year with fourth quarter 2022 earnings of $15.4 million and diluted earnings per share ("EPS") of $1.05, each an 8% increase over the third...

at 08:15
With only a tiny fraction of Mexicans having health insurance or access to the necessary credit or savings, a medical emergency can be a catastrophic event as evidenced by the recent COVID-19 pandemic that hit Mexico harder than the rest of North...

at 08:10
AMC Entertainment Holdings, Inc., , the largest theatrical exhibitor in the United States, in Europe & the Middle East and in the world, today announced that following the successful launch of movie theatre operations in the Kingdom of Saudi Arabia...



News published on 1 december 2022 at 05:45 and distributed by: